In addition, recent works evaluated the impact of biallelic BIRC3 loss in CLL cases harboring 11q deletions showing that BIRC3 mutations in del(11q) cells promote clonal advantage in vitro and accelerate leukemic progression [96]. The gene discussed is BIRC3; the disease is B-cell chronic lymphocytic leukemia.